Transcriptomics Technologies Market Size 2021 Emerging Trends, Growing At a CAGR of 16.3%, Development Status, Future Demands, Market Potential, Regional Overview and SWOT Analysis till 2027

SEATTLE, May 04, 2021, (PHARMIWEB) —

The study of the shapes and roles of transcript molecules is known as transcriptomics. The fundamental dogma method includes data on the flow of genetic knowledge in a biological environment. Transcriptome analysis is more complicated than genome analysis since a single gene will generate many forms of mRNA molecules.

Statistics:

The global transcriptomics technologies market is expected to account around US$ 15,569.1 Mn in terms of value by the end of 2027.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/3989

Market Drivers:

Rising research and development investments is expected to drive growth of the global transcriptomics technologies market during the forecast period. For instance, according to The European Federation of Pharmaceutical Industries and Associations’ Key Data 2019, the pharmaceutical sector in Europe invested US$ 19,509 million in 2000, which increased to US$ 39,895 million (est.) in 2018.

Market Opportunities:

Rising incidences of cardiovascular diseases is expected to pose growth opportunities for major players in the global transcriptomics technologies market. For instance, according to American Heart Association 2019 Heart Disease and Stroke Statistics, cardiovascular disease was responsible for 840,768 deaths (635,260 cardiac) in 2016 in the U.S.

Market Restraints:

RNA depletion is expected to hamper growth of the global transcriptomics technologies market over the forecast period. Since the results of RNA degradation are not always consistent, sequenced data’s ability to accurately portray in vivo gene expression is significantly harmed.

Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/3989

Market Trends:

Key players are concentrating on a number of approaches to expand their market share in the global transcriptomics technologies market. For instance, June 2019, Bio-Rad Laboratories, Inc. participated in Jefferies 2019 Global Healthcare Conference, held in New York, U.S.

The market’s major players are also focusing on merger & acquisitions approaches to broaden their product range. For instance, in November 2018, Agilent Technologies Inc. acquired ACEA Biosciences Inc., a developer of cutting-edge cell analysis tools, for US$ 250 million in cash.

Competitive Landscape:

Key players operating in the global transcriptomics technologies market such as, Agilent Technologies, Inc., Affymetrix, Inc., Inc., Danaher Corporation, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd.,  Illumina, Inc., Life Technologies Corporation, LLC, Qiagen N.V. and LC Sciences.

Market: Key Developments

The market’s major players are also focusing on merger & acquisitions approaches to broaden their product range. For instance, in March 2020, Thermo Fisher Scientific Inc. announced to acquire QIAGEN N.V., a provider of molecular diagnostics and sample preparation technologies.

Key market players are now focusing on the acceptance and launching of new products in order to broaden their product range. For instance, in March 2019, F. Hoffmann-La Roche Ltd. received the U.S. Food and Drug Administration (FDA) approval of the VENTANA PD-L1 (SP142) Assay, as the first companion diagnostic to aid in identifying triple-negative breast cancer (TNBC) patient’s eligible for treatment with the Roche cancer immunotherapy Tecentriq (atezolizumab) plus chemotherapy.

Buy This Complete A Business Report: https://www.coherentmarketinsights.com/insight/buy-now/3989

Segmentation

Global Transcriptomics Technologies Market, By Technology:

• • Microarrays
  • PCR
  • Gene Regulation Technologies
  • Next Generation Sequencing

Global Transcriptomics Technologies Market, By Application:

• • Clinical Diagnostics
  • Drug Discovery & Research
  • Bioinformatics
  • Comparative Transcriptomics

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/transcriptomics-technologies-market-3257

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contacts US:

Mr. Shah
Coherent Market Insights,
1001 4th Ave,
#3200 Seattle, WA 98154, U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com